Alcon, Allergan, AMO, Bausch & Lomb, Ciba Vision, Cooper Vision, Paragon Visio Sciences, SynergEyes, & Vistakon

Similar documents
Case no.4. Subjective. Subjective (2) Caucasian female, 62 Y.O., consulting for a XXX opinion on her condition.

9/15/2016. Fitting Beyond The Ordinary 2016 Using New Technologies: Case by Case

founder of McDonald s Restaurants

No Conflict of Interest to Report Charles Stockwell, O.D

Ophthalmology Times Case Study Yasmin Mali, MD. Case Study

9/23/2014. Emily Thomas, O.D. MOA Paraoptometric Education October 5, 2014

Breaking the Cycle. Yijie (Brittany) Lin, MD, MBA, Reena Garg, MD New York Eye and Ear Infirmary of Mount Sinai

Ocular Allergies: Scratching the Surface. -20%-50% of the population has allergies -83% of allergy sufferers experience ocular symptoms

ICD-10-CM Workshop. John A. McGreal Jr., O.D. Missouri Eye Associates McGreal Educational Institute. Excellence in Optometric Education

Six Things That Changed How I Manage Graves Disease

Bruce H. Koffler, M.D. Lindsay Koffler Cassidy, COT, OSC

OPHTHALMOLOGIC PEARLS FOR THE NON- OPHTHALMOLOGIST. David G. Gross D.O. Deen-Gross Eye Centers Merrillville-Hobart Deengrosseye.

PAINFUL PAINLESS Contact lens user BOV

Ocular Manifestations of Systemic Disease: Grand Rounds Kimberly K. Reed, O.D., FAAO

Dr. Litwak is on the speaker bureau and advisory panel for Alcon and Zeiss Meditek

A Curious Case of Bilateral Optic Disc Edema Brittney Dautremont, DO, MPH

Fitting Keratoconus and Other Complicated Corneas

Overview & pathophysiology of Dry Eye and the use of cyclosporine eye drops in dry eye...

How Strongly Do You Feel That This Patient Has Glaucoma? % % % % %

My Favourite Cases Anthony B. Litwak, OD, FAAO VA Medical Center Baltimore, MD

Alternative Treatment Options to Common Ocular Disease

Comparison of management options for scleral buckle exposure

NORTHEAST OHIO NEIGHBORHOOD HEALTH SERVICES, INC. OPTOMETRIC MEDICINE CLINICAL GUIDELINES: TABLE OF CONTENTS

Clinical Use of Therapeutic Bandage Contact Lenses Bruce Baldwin, OD, PhD, FAAO, FSLS

Bill Kilgore, LDO,NCLE,COA Virginia Mason Medical Center

30 Years of Clinical Challenges

ACMO SAMPLE PATIENT 1

Pearls for the Refractive Technician Fadiah Alkhawaldeh, IMBA, COT, ROUB

Comments. Oral Antihistamines. Chronic Drug Treatments. Oral Allergy Medications

Dry Eye Assessment and Management Study ELIGIBILITY OCULAR EVALUATION FORM

DISCLOSURES. PEDIATRIC RED EYES Rachel M. Smith, OD, FCOVD HISTORY, HISTORY, HISTORY WHY RED EYES? EXAMINE THE EYE RED FLAGS TO REFER 3/25/2019

! Women greater than men (4:1)» Typical of other autoimmune diseases

History. Examination. Diagnosis/Course

John Rawstron Christchurch 2015

Ophthalmic Immunomodulators Prior Authorization with Quantity Limit Program Summary

Sepideh Tara Rousta, MD FAAO Robert Wood Johnson University Hospital Saint Peter s University Hospital Wills Eye Hospital

OCULAR SURFACE DISEASE SYNDROMES WAYNE ISAEFF, MD LOMA LINDA UNIVERSITY DEPARTMENT OF OPHTHALMOLOGY

Learning Objectives. Disclosures 2/2/ BMT Pharmacists Conference Bandage Contact Lens Therapy for Severe Ocular GVHD

Patient Symptoms- What They Might Mean. Sarah Dougherty Wood, OD, MS, FAAO Heart of America, February 2011 Paraoptometric Lecture

Predisposing factors. Gender. Ocular Surface Disease. Ocular Surface Disease Health. Building a Dry Eye Practice

Dr Rachael Neiderer. Ophthalmologist Auckland. 8:35-8:50 Managing Allergic Conjunctivitis & Why Sodium Chromoglycate is Out

a.superficial (adenoid layer).contain lymphoid tissue.

My Doc told me I needed an eye exam because.. Bruce Onofrey, OD, RPh, FAAO Professor, U. Houston UEI

Phone Triage for Optometric Staff ???????? CHEMICAL BURN CHEMICAL BURN

Differential Diagnosis in Anterior Segment Disease. Paul M Karpecki, OD, FAAO Kentucky Eye Institute Lexington KY

Dry eye syndrome is more likely to affect people who are over the age of 60, and the condition is more common among women than men.

Advanced Diagnosis and Management of OSD and Tear Dysfunction

Disclosures and Special Request. Agenda. What s Up with OSD? Case 23/05/2013. OSD presents a significant challenge to

3/14/2016 SLEEP APNEA AND THE EYELIDS PATHOGENESIS. Floppy Eyelid Syndrome. Sara Nonhof, O.D. Mechanical theory. Decreased tarsal elastin.

Anatomy: There are 6 muscles that move your eye.

Scleral Lenses: How do you know what is best

Ocular Allergy. Phil Lieberman, MD

How I Met Your Cornea

5/24/17. ***Varicella-Zoster Virus*** Herpes DNA virus that causes 2 distinct syndromes

OPHTHALMOLOGY REFERRAL GUIDE FOR GPS

What was going on. Thyroid Related Orbitopathy. Pathophysiology. Definition GALLO EYE AND FACIAL PLASTIC SURGERY 3/16/2017

1/3/17. ***Varicella-Zoster Virus*** Herpes DNA virus that causes 2 distinct syndromes

HELP HEAL YOUR PATIENTS DRY EYES.

Predisposing factors. Gender. Ocular Surface Inflammation and Infection Control. Ocular Surface Disease 8/7/12. Ocular Surface Disease Health

Oral azithromycin combined with topical anti-inflammatory agents in the treatment of blepharokeratoconjunctivitis in children

DEWS Severity Analysis 11/30/12. Blephari/s, MGD and Ocular Surface Disease. Ben Gaddie, O.D., F.A.A.O. Louisville, KY

Pardon the Objection: Cases Marc R. Bloomenstein OD, FAAO Scot Morris, OD Derek Cunningham, OD Kathy Mastrota, OD

Challenging Anterior Segment Cases. Benjamin P. Casella, OD, FAAO

Medical and/or Vision Insurance plans do not cover the Specialty Dry Eye Testing or LipiFlow services.

Provided as a service by CiplaMed

OOGZIEKTEN VOOR DE HUISARTS F. GOES, JR.

Patient information leaflet Thyroid Eye Disease

Mom, There s Something Wrong With My Eye

By Darlene Jones, Nurse. May 2017

Question 1: Discuss your further examination of this patient with respect to her current symptoms

Strategies for Anterior Segment Disease Management Mile Brujic, OD, FAAO 1409 Kensington Blvd Bowling Green, OH

A Case of Carotid-Cavernous Fistula

Therapeutical bandage contact lenses for corneal protection

The Emergent Eye in the Acute Setting

Neuro Ocular Grand Rounds Anthony B. Litwak, OD, FAAO VA Medical Center Baltimore, MD

Financial Disclosures. Corneal Problems for the Cataract Surgeon. Four Common Problems. Dry Eye syndrome. Rose-Bengal 3/27/16

Case History. Patient demographics: - 74 year old Caucasian White Female

Cataract Surgery Co-Management

Page 1 RED EYES. conjunctivitis keratitis episcleritis / scleritis. Frank Larkin Moorfields Eye Hospital. acute glaucoma anterior uveitis

Clinical Practice Guide for the Diagnosis, Treatment and Management of Anterior Eye Conditions. April 2018

DISCLOSURE: What to do? 2/22/2016

RED EYE, RED EYE What do YOU See???

Dry Eye Disease Diagnosis and Treatment Pearls from the Trenches (2 hours) Mile Brujic, O.D Kensington Blvd. Bowling Green, OH 43402

THYROID EYE DISEASE. A General Overview

Test Bank for Medical Surgical Nursing An Integrated Approach 3rd Edition by White

People with eye allergies typically have symptoms that include: Eye Anatomy: What Do Eye Allergies Actually Effect?

PRECISION PROGRAM. Injection Technique Quick-Reference Guide. Companion booklet for the Video Guide to Injection Technique

Dry Eye Syndrome Prescribing Guidelines

Title: Keeping Step with DEWS2: Clinical Applications Lecturer: Scott G. Hauswirth, OD

5/2/2016 EYE EMERGENCIES. Nathaniel Pelsor, O.D., FAAO Talley Medical-Surgical Eye Care Associates. Anatomy. Tools

The following is a list of medications which are known to have high risk of ocular side effects

Do You Want Steroids with THAT?! Bruce Onofrey, OD, RPh, FAAO

Case History. The SEVEN HABITS of Highly Effective Anterior Uveitis Management. SLEx findings: SLEx corneal findings: y.o.

Ophthalmology. Ophthalmology Services

12/3/2011. Disclosure. Allergic Eye Disease: Diagnostic Pearls and Treatment Options. Symptoms. Allergy Eye Disease

Allergic Conjunctivitis

ICD-10 Coding for Contact Lens Problems. The EyeCodingForum.com

Management of Diplopia Indiana Optometric Association Annual Convention April 2018 Kristine B. Hopkins, OD, MSPH, FAAO

Differential Diagnosis of Conjunctivitis and Keratoconjunctivitis

Transcription:

Not Your Typical Dry Eye Clinical Considerations for Complex Cases American Academy Of Optometry November 12, 2009 Orlando, FL Michael DePaolis, OD, FAAO Visionary Eye Associates & University of Rochester Medical Center Rochester, NY mgadep@aol.com FINANCIAL DISCLOSURE STATEMENT Clinical Investigator, Advisory Panel, Consultant Alcon, Allergan, AMO, Bausch & Lomb, Ciba Vision, Cooper Vision, Paragon Visio Sciences, SynergEyes, & Vistakon Optometric Editor, PRIMARY CARE OPTOMETRY NEWS Independent Board of Director, TLC Vision Not Your Typical Dry Eye Clinical Considerations for Complex Cases Case 1 KI (63 yof) cc: Red, irritated eyes x 6 months. +fb sensation. +grittiness. +photophobia. + variable vision. Moderate intensity. No significant discharge. Systemic hx: +asthma. +arthritis. +hypothyroid. +depression. + seasonal allergies. No recent uri. Medications: Advair, glucosamine/chondroitin, levothyroxine, & sertraline qd. Claritin D prn. NKDA. Family hx: Father AMD. Social hx: No smoking. Minimal alcohol. Medical receptionist

Case 1 KI (63 yof) Neuro: +alert, +calm, +well oriented. Va: OD +7.75 0.25x180 /+2.50 = 20/50 & OS +8.25 1.25x4 / +2.50 = 20/70 Externals: Perrla ( )apd, eom f & s, cvf ftfc ou. No adenopathy. Iops: 14 OD & 14 OS goldmann @10am. Dfe: 0.35x0.35 OD & 0.4x0.4 OS with healthy nrr ou, vasculature normal ou, macula clear ou, posterior pole flat ou, +vitreous floathers ou. Biomicroscopy: Gr 1+ mgd ou, Gr 2 nasal & temporal LG conjunctival staining ou, Tear prism < 0.25 mm ou, Corneal filaments ou & gr1 ebmd ou, TBUT < 5 sec ou, Gr 2 exposure keratitis ou, Ac d&q ou, Iris normal ou, Gr1 nuclear sclerotic cataract ou Keratoconjunctivitis sicca ou, Epithelial basement membrane dystrophy ou, Filamentary keratitis ou, Nuclear sclerotic cataract ou 1. In office removal of filaments ou 2. Tobradex ung ou qid 3. Systane ou qid 4. Hot compress ou bid 5. f/u 1 week Case 1 KI (63 yof) 1 week f/u Cc: eyes feel about 50% better. Complying with all tx. c/o ung blurring va. No change in systemic health or meds. Neuro: Alert, calm & well oriented. Va: With habitual Rx OD 20/30 & OS 20/40 Externals: Perrla, eom f & s, and cvf ftfc ou. Biomicroscopy: Gr 1+ mgd ou, Gr 2 nasal & temporal LG conjunctival staining ou, Tear prism < 0.25 mm ou, Gr1 ebmd ou, TBUT < 5 sec ou, Gr 1 exposure keratitis ou, Ac d&q ou, Iris normal ou, Gr1 nuclear sclerotic cataract ou

Keratoconjunctivitis sicca ou, Epithelial basement membrane dystrophy ou, Nuclear sclerotic cataract ou 1. Tobradex ung ou bid x 2 week, then d/c 2. Restasis ou bid 3. Systane ou q2h 4. Hot compress ou bid 5. Increase hydration, limit caffeine, increase dietary omega 3 s Case 1 KI (63 yof) 3 week f/u Cc: eyes feel no better. Complying with all tx. c/o blurring va. No change in systemic health or meds. Neuro: Alert, calm & well oriented. Va: With habitual Rx OD 20/30 & OS 20/50 Externals: Perrla & eom f & s. Biomicroscopy: Gr 1+ mgd ou, Gr 1 nasal & temporal LG conjunctival staining ou, Tear prism < 0.25 mm ou, Gr1 ebmd ou with nasal & temporal Salzman s nodules ou!!, TBUT < 5 sec ou, Gr 1 exposure keratitis ou, Ac d&q ou, Iris normal ou, Gr1 nuclear sclerotic cataract ou Keratoconjunctivitis sicca ou, Epithelial basement membrane dystrophy ou, Salzman s corneal degeneration ou, Nuclear sclerotic cataract ou 1. Parasol punctal plug LL OU 2. Night & Day 84 140 +050 ou qd / Clear Care ou qhs 3. Restasis ou bid 4. Systane ou q2h 5. Hot compress ou bid 6. Increase hydration, limit caffeine, increase dietary omega 3 s

Case 1 KI (63 yof) 2 month f/u Cc: eyes feel much better. Complying with all tx. c/o blurring va. No change in systemic health or meds. Neuro: Alert, calm & well oriented. Va: With habitual Rx OD 20/25 & OS 20/40 * Externals: Perrla & eom f & s. * Oh, by the way, my left eye is my lazy eye!!! Biomicroscopy: Each contact lens is central and mobile, Gr 1 mgd ou with punctal plug LL ou, Trace nasal & temporal LG conjunctival staining ou, Tear prism ~ 0.50 mm ou, Gr1 ebmd ou without filaments, nodules, or staining, TBUT < 5 sec ou, Ac d&q ou, Iris normal ou, Gr1 nuclear sclerotic cataract ou Keratoconjunctivitis sicca ou, Epithelial basement membrane dystrophy ou, Nuclear sclerotic cataract ou 1. D/C bandage lenses 2. Restasis ou bid 3. FreshKote ou bid, Systane ou prn 4. Hot compress ou qhs 5. TheraTears Nutrition po bid Case 1 KI (63 yof) Questions for consideration 1. Would a daily disposable have worked as well? 2. Would have upper lid punctal occlusion been a better option than bandage lenses? Doane Ophth 98(8):1981 UL occlusion slows Krehbiel flow 2. Would you consider ultimately tapering Restasis to qd? 3. What do you recommend for omega 3 supplementation? 4. Why FreshKote gtt? What do you recommend for omega 3 supplementation? Omega 6 fatty acids

Linoleic acid in all vegetable oils. BAD Gamma Linolenic acid in black current oil, borage oil, evening primrose oil Omega 3 fatty acids Alpha Linolenic acid black current oil & flax EPA fish oil & cod liver oil DHA fish oil & cod liver oil Case 2 AD (71 yof) cc: Irritated, watery eyes x 2 years. +grittiness. +photophobia. + variable vision. Moderate intensity. No significant discharge. Hx of dry eye. Limited relief with Genteal, Hypotears, and Systane gtt. Prefers TheraTears ou qid. Has Rosacea dermatologist Rx d tetracycline & eyes felt better. D/c d tetracycline due to yeast infection. Elestat ou bid prn. Systemic hx: +atrial fib. +arthritis. +gerd. +anxiety. + seasonal allergies. +rosacea. No recent uri. Medications: Atenolol, Tylenol, Zantac, Lexapro, & Clarinex qd. Rosula lotion prn. Case 3 JS (40 yom) Cc: c/o eye fatigue, strain, burning, grittiness, and photophobia x 18 months. PRK OU 18 months ago for myopia & astigmatism. Hx of dry eye and contact lens intolerance. Systemic hx: Seasonal allergies, dermatitis, & clinical depression. Medications: Claritin prn. Nizoral shampoo. KNDA. Family Hx: mgm with glaucoma. Social Hx: No nicotine. Social alcohol consumption. Graphic artist. Neuro: Alert, calm, and well oriented. Introverted. VA: OD sc 20/40 & OS sc 20/70. Externals: Perrla / no apd / 6mm ou. Eom f & s. Cvf full ou. IOP s: 15 OD & 15 OS goldmann @ 8:15am.

Dfe: 0.4x0.4 with HNRR, normal vasculature, macula clear, vitreous clear, posterior pole and periphery intact ou. Biomicroscopy: Gr1 blepharitis & mgd ou, Trace LG conjunctiva stain ou, Tear prism < 0.5mm ou, TBUT ~ 10 seconds ou, Arcuate corneal haze OD, Central corneal haze OS, AC d & q ou, Iris normal ou, Lens clear ou Pre operative Rx: OD 7.50 0.50 x 165 = 20/15 & OS 7.00 0.75 x 170 = 20/15 Post operative Rx: OD +1.50 1.25 x 21 = 20/25+ & OS 1.25 0.75 x 142 = 20/25+ Keratometry: OD 37.78 x 39.32 & OS 39.87 x 40.95 Blepharitis ou, Keratoconjunctivitis sicca ou, Corneal scar (haze) ou, Hyperopia & astigmatism OD / Myopia & astigmatism OS, Asthenopia ou 1. Lid hygiene, hot compresses, and Zylet ou bid 2. Blink ou qid 3. Extended duration collagen plugs LL ou 4. F/u in one month Case 3 JS (40 yom) 1 month f/u Cc: Eyes feel much better. Still experience eye strain, fatigue, and photophobia. Complying with all tx. No change in systemic hx or medications. Neuro: Calm, alert, and well oriented. Externals: Perrla (no apd), eom f & s, no periocular dermatitis. VA: With habitual Rx OD 20/30+ & OS 20/30. Biomicroscopy: No blepharitis, gr1 mgd, conjunctiva clear, cornea stable. Tear prism ~ 0.5mm & TBUT > 10mm Improved keratoconjunctivitis sicca ou, Resolved blepharitis ou, Corneal scar (haze) stable ou, Anisametropia with asthenopia ou.

1. PureVision toric 87 +1.50 1.25 x 20 OD & 1.50 0.75 x 140 OS. Clear Care qhs and Replace lenses q1 month. 2. Daily lid hygiene. 3. Blink ou qid. 4. Surgical enhancement pending. Case 3 JS (40 yom) Questions for consideration 1. Should we have JS on Restasis as well? Peyman, etal ASCRS 2007 (poster) 1. Are permanent punctal plugs indicated? 2. What should our surgical plan be for JS? 3. Does vitamin C play a role in the peri operative care of patients such as JS? POST PRK HAZE PREVENTION Stojanovic, etal J Ref Surg 19(3):2003 N = 314 Eyes Tx w/o Vitamin C N = 204 Eyes Tx w Vitamin C (500mg po bid x 3 wks) Haze was significantly less at 1 week & 1, 3, & 6 month visits in the Vitamin C group Late presenting haze in 11 eyes in the group w/o Vitamin C & in 0 eyes in the Vitamin C group Case 4 KL (36 yof) Cc: c/o extreme dry eye and diplopia ou. Hx of MVA with bilateral 7 th N crush injury. +lagophthalmus +neurotropic keratitis. Acute bilateral corneal ulceration tx with partial tarsoraphy, punctal cauterization, & moisture chamber goggles. Now uses saline gtt ou q15 minutes, ung ou qhs, Pred Forte ou bid. Systemic hx: Excellent. No medications taken. NKDA. Family Hx: non contributory. Social Hx: No nicotine. No alcohol. Office administration. Neuro: Alert, calm, and well oriented. VA: OD +3.25 2.00 x 4 = 20/100 OS +1.50 3.50 x 120 = 20/400. Externals: Perrla (no apd), EOM constant OS 20pd et, cvf grossly ftfc ou.

IOP s: 15 OD & 14 OS goldmann @ 10 am. Dfe: 0.3x0.3 with HNRR, normal vasculature, clear macula, posterior pole flat, vitreous clear and periphery intact ou. Biomicroscopy: Bilateral punctal occlusion ou, Conjunctiva clear ou, Cornea with stromal neovasc and stromal scarring ou, AC d & q ou, Iris normal ou, Lens clear od & Gr3 NS os Neurotrophic keratoconjunctivitis sicca ou, Corneal neovascularization ou, Cornea scar ou, Esotropia os Cataract os 1. Continue with sterile saline ou prn 2. Pataday ou qam & Alrex ou qhs 3. Return for therapeutic contact lens fitting Case 4 KL (36 yof) 2 week f/u Cc: Here for therapeutic contact lens fitting. No changes. Compliant with all tx. No change in systemic history or meds. Neuro: Alert, calm, and well oriented. VA: With habitual Rx OD 20/100 and OS 20/400. Externals: Perrla (no apd) and eom constant 20pd OS et. Biomicroscopy: Eyelids with punctal cautery, conjunctiva clear, corneal neo and scar stable, AC d & q, and iris normal ou. Lens clear OD and gr 3 nuclear sclerosis OS. Diagnostic fitting: OD SynergEyes 780 14.5 1.50 8.8 sc Central, acceptable mvmt, VA = 20/20 OS B&L Soflens 1 day 86 140 +300 Central, optimal mvmt, VA = < 20/400 Neurotrophic keratoconjunctivitis sicca ou, Corneal neovascularization ou, Corneal scar ou, Esotropia os Cataract os

1. Dispense SynergEyes OD & Soflens 1 Day OS 2. Aosept Clear Care qhs 3. Pataday ou qam & Alrex ou qhs 4. Sterile saline gtt ou q prn Case 4 KL (36 yof) 1 month f/u Cc: Eyes feel much better. Vision great! CL s ou qd x 14 hrs. Compliant with lens care and all tx regimens. Using saline gtt q 1h. No change in systemic health or medications. Neuro: Alert, calm, and well oriented. VA: With CL s OD 20/20 & OS <20/400. Externals: Perrla (no apd), eom 20pd os et. Biomicroscopy: Eyelids normal, Conjunctiva clear, Cornea stable / no spk, AC d & q, Iris normal Lens clear OD & Gr3 NS OS Neurotrophic keratoconjunctivitis sicca ou, Corneal neovascularization ou, Corneal scar ou, Esotropia os, and Cataract os. 1. Continue with CL s ou qd and Aosept qhs. 2. Continue with Pataday ou qam and Alrex ou qhs. 3. Continue with sterile saline gtt ou prn (decreasing dosage). 4. F/u visit in 2 months. Case 4 KL (36 yof) Questions for consideration 1. Should I have prescribed Restasis? 2. Should I a prescribe a prophylactic antibiotic gtt qhs? 3. Should we more aggessively address the corneal neovascularization ( argon laser or anti vegf)?

4. Is there any other tx options for neuroparalytic keratoconjunctivitis sicca? Case 5 RA (52 yom) Cc: I think my allergies are affecting my eyes. +itch +tear +irritation. No significant discharge. No blurred va. No recent URI. Systemic hx: Hypothyroidism. Seasonal allergies. Medications: Synthroid qd. Claritin D prn. Family hx: Father with brvo. Social hx: No nicotine. No alcohol. Catholic Priest (ok, maybe a little wine once in a while). Neuro: Alert, calm, and well oriented. VA: Habitual Rx OD 20/20 & OS 20/20. Externals: Perrla (no apd). Mild LL edema. Biomicroscopy: Gr1 inferior follicles ou, Gr1 conjunctival chemosis ou, Trace EBMD ou, AC d & q ou, Iris normal ou, & Lens clear ou Allergic conjunctivitis ou, Epithelial basement membrane dystrophy ou. 1. Allergen avoidance. 2. Cool compress ou prn. 3. Patanol ou bid. 4. F/u visit in 2 weeks. Case 5 RA (52 yom) 1 month f/u Cc: Eyes feel a little better. + grittiness + burning. Tearing causing double vision. Very compliant with all tx. No change in systemic health or medications. Neuro: Alert, calm, and well oriented. VA: Habitual Rx OD 20/20 & OS 20/20. Externals: Perrla (no apd), eom diplopia in extreme lateral gaze, cvf ftfc ou. Exophthalmometry 23mm od & 24mm os.

Dfe: 0.3x0.3 with HNRR, normal vasculature, macula clear, posterior pole and periphery intact, vitreous clear ou. Biomicroscopy: Gr1 follicles LL ou, Gr1+ superior bulbar conjunctival injection ou, Gr1+ superior spk ou, AC d & q ou, Iris normal ou, Lens clear ou IOPs: 19 od 19 os goldmann @ 4pm. Allergic conjunctivitis improved ou, Superior limbic keratoconjunctivitis ou, Epithelial basement membrane dystrophy ou, & Thyroid orbitomyopathy ou. 1. Punctal plugs UL ou 2. Lotemax ou bid 3. Optive ou qid 4. Gen Teal gel ou qhs 5. Orbital consult Case 5 RA (52 yom) Orbital consult results Endicinology Labs TSH, T3, & T4 levels normal Orbital CT scan EOM infiltration with fat distention Non responsive to oral prednisone up to 60mg po qd Bilateral 2 wall orbital decompression ou Eventual resolution of diplopia sx Case 5 RA (52 yom) Questions for consideration 1. What is the underlying pathophysiology of SLK? 2. Is there a better way to treat SLK? Tsubota, etal 3. When are imaging studies indicated in suspected thyroid eye disease (TED)? Ben Simon, etal Ophth Surg Las Im 37(4):2006. 4. What % of TED patients have normal laboratory studies?

Etiology of thyroid orbitomyopathy Autoimmune inflammation of eom s & orbital fat increasese orbital bulk > increases apex pressure Restriction of retropulsion > increases optic neuropathy Exophthalmos > increases corneal involvement EOM inflammation & fibrosis > Restricts ductions Associated Risk Factors : Thyroid disturbance, antigen release, infection, malignancies, & smoking Treatment : Orbital radiotherapy, Orbital decompression Immunotherapy IV methylprednisone, oral prednisone, cyclosporin, somatostatin analogs (?) Moorfields Eye Hosp Eye 20(10):2006 N = 6 patients with inactive thyroid disease All patients had symptoms of postural TVO Elevated IOP s, ONH swelling, exophthalmos, & restricted ductions Orbital wall decompression effective treatment Ben Simon, etal Ophth Surg 37(4):2006 N = 595 patients with thyroid orbitopathy N = 20 (3.4%) developed optic neuropathy Tx: Orbital decompression & oral prednisone Results: Mean VA 20/150 > 20/30, Color vision 5/14 plates > 11/14 plates, APD reversed in 25/26 eyes Exophthalmos decreased from mean 26.4mm > 21.5mm HOW SIGNIFICANT IS SMOKING? Thornton, etal Eye 20(9):2006 Meta analysis of 15 peer reviewed studies Evaluated significance of smoking

Results: Graves disease patients who smoke are at increased risk of developing thyroid eye disease Graves ophthalmopathy patients who smoke have more rapid progression of thyroid eye disease Graves ophthalmopathy patients who smoke have poorer treatment outcomes Clinical Case: DC 44 yof Ocular History: Previously wore soft contact lenses, but d/c due to dryness Referred by corneal specialist Has tried Optive, Systane, & TheraTears as well as Pred Forte & Alrex Current eye gtt: Patanol ou bid, Restasis ou bid. Cc: I get eye hemorrhages q 1 mth. I d like to get back into wearing contact lenses if possible. Systemic History: (+) Anxiety. ( ) Thyroid. ( ) Arthritis. ( )Rosacea. ( ) Blood dyscrasias / hematology work up. Medications: Fluoxetine qd, Fish oil qd. VA: OD Rx 20/20 & OS Rx 20/20. Externals: (+) malar flush Biomicroscopy: Grade 3 mgd ou, Grade 2 conjunctival chalasis ou, Grade 1 LG stain ou, Cornea clear with TBUT < 10 sec ou, Tear prism <0.5mm ou, AC d&q ou, Iris normal, lens clear ou 1. Keratoconjunctivitis sicca ou 2. Ocular rosacea ou 3. Menstrual related subconjunctival hemorrhage ou 1. Spoke with ob gyn r/o ocular endometriosis 2. Spoke with pcp rosacea 3. Hot compresses with digital massage ou bid

4. Lotemax ou bid, Patanol ou bid, & Restasis ou bid 5. TheraTears nutrition 2 softgels po qd 1 month f/u 1. Hot compresses with digital massage ou bid 2. Restasis ou bid, Soothe ou tid, & Patanol ou prn 3. Parasol punctal plug LL ou 4. Doxycycline 50 mg po bid x 2 wks, 50 mg po qd 5. TheraTears nutrition 2 softgels po qd. 3 month f/u: CC: doing great, no hemorrhages in 2 months. VA: OD Rx 20/20 & OS Rx 20/20. Biomicroscopy: Grade 1 mgd, grade 1 conjunctival chalasis w/o LG stain ou, cornea clear with TBUT ~ 10 sec ou, ac d&q ou, iris normal ou, lens clear ou. 1. Continue hot compress ou 2. Continue Restais ou bid & Patanol ou prn 3. Continue Theratears Nutrition po qd 4. Doxycycline 50 mg po qod 5. Proclear daily disposable OD 8.6 14.2 3.75 & OS 8.6 14.2 3.50 Questions for consideration. 1. Is it safe for this patient to resume contact lens wear? 2. Do you prefer a daily disposable or a silicone hydrogel for patients with this degree of dryness? 3. When is a conjunctivoplasty indicated? 4. If the menstrual cycle subconjunctival hemorrhages return, is a low dose oral contraceptive indicated?